BioSpace News Archive

Isofol enters licensing agreement with Solasia to develop and commercialize arfolitixorin in Japan

Isofol Medical AB, announced that it entered into a license agreement with Solasia Pharma K.K, a specialized oncology company headquartered in Japan, to develop and commercialize Isofol’s proprietary late-stage drug candidate arfolitixorin in Japan.

August 13, 2020
·
6 min read
Healthcare Interoperability Solutions Market Detailed Study Analysis and Forecast by 2028

The development of this market is essentially determined by the developing need to control expanding healthcare costs, government activities for upgrading patient consideration and wellbeing.

August 13, 2020
·
4 min read
Cardiac Rehabilitation Market: Elliptical Trainer Most Profitable Device Segment

At a significant Compound Annual Growth Rate of 5.4%, the global cardiac rehabilitation market is set to gain from an increase in geriatric population and an ever increasing burden of cardiovascular diseases.

August 13, 2020
·
5 min read
Metabolomics Market: Development in Pharmaceutical Sector Fuels Market Growth

Transparency Market Research in its new report predicts that the global metabolomics market will undergo a tremendous transformation in the near future.

August 13, 2020
·
4 min read
Urinalysis Market: Growing Diabetic Population to Drive the Market

The global urinalysis market is marked by fierce competition among the leading players. Most companies are keen on developing new technology to improve efficiency of test results and reduce time.

August 13, 2020
·
4 min read
Pulmonary Drugs Market Mainly Drive by the Increasing Instances of Chronic Respiratory Disorders

Stiff competition prevails in the global market for pulmonary drugs, which are used to treat respiratory disorders.

August 13, 2020
·
3 min read
Pharm Country

Cognizant Named a Healthcare Payer Operations Leader by Everest Group

Report Highlights Cognizant’s Digital Capabilities as Key to Addressing Healthcare Payer Challenges

August 13, 2020
·
3 min read
Deals

NTN Buzztime, Inc. and Brooklyn ImmunoTherapeutics LLC Enter into Definitive Merger Agreement

Proposed merger will create a public company focused on the clinical development program of a cytokine-based product for the treatment of cancer

August 13, 2020
·
15 min read
Biotech Bay

Applied StemCell Awarded ~USD 2 mil NIH grant for Advancing its TARGATT Technology for Therapeutic Gene Editing

Applied StemCell, Inc., a leading gene editing company focused on the development of enabling tools for cell and gene therapy has been awarded close to $2.0 million US dollars in a Small Business Innovation Research grant from the NIH.

August 13, 2020
·
1 min read
Biotech Beach

ChemDiv Created Unique KATO TM Platform for Development of Innovative Drugs Against Coronavirus Infection

ChemDiv Inc., a fully integrated California-based CRO, announced the creation of a unique platform for development of drugs against coronavirus infection that would simplify and accelerate antiviral candidate selection.

August 13, 2020
·
3 min read